NPPB and pulmonary arterial hypertension: In this study, we applied GBTM-based trajectory analyses to repeated measurements of NT-proBNP within 1 year from baseline in a clinically, experimentally, and hemodynamically-confirmed CTD-PAH cohort, and we subsequently evaluated the association between NT-proBNP trajectories and prognosis.